Seaport Research analyst Scott Graham lowered Badger Meter's price target to $220 from $255, citing a slower sales pace in early 2025. The firm maintains a Buy rating, anticipating a stronger second half. The water technology company recently reported record annual sales and profits.
While investors chase AI and big tech, a niche biotech firm focused on rare genetic obesity disorders has quietly delivered staggering returns, with Wall Street seeing further 40% upside. Rhythm Pharmaceuticals' targeted approach and upcoming catalysts have analysts bullish, despite its relative anonymity.
While Tesla's stock remains resilient, the promise of a self-driving future presents both staggering potential and significant hurdles for investors to consider.
The spirits giant files for legal protection for its production and warehouse assets in Latvia, citing cash flow pressures from geopolitical fallout and market headwinds, while assuring global sales remain unaffected.
A new analysis reveals a stark geographic divide in credit health, with residents in several Southern states facing higher long-term mortgage costs due to lower average credit scores, while Northern states benefit from more favorable rates.
Mazda Motor Corporation's global vehicle production saw a significant rebound in December 2025, offering a positive end to a year where overall output and sales declined. The recovery was driven by strong domestic performance and a mixed picture overseas.
Crude oil benchmarks plunged over 7%, with Brent near $66 and WTI around $62, as President Trump's comments eased fears of a U.S.-Iran conflict and a sell-off in metals markets spilled over. Analysts suggest the drop reflects a rapid unwinding of risk premiums rather than a fundamental change in supply dynamics.
Terns Pharmaceuticals has restructured a key licensing deal with China's Hansoh, gaining exclusive worldwide rights for its TERN-701 oncology drug outside Greater China. The strategic move, coupled with a recent analyst price target surge, signals the company's aggressive push into international markets.
President Trump's apparent endorsement of a weaker dollar is not mere rhetoric but a strategic pillar of his economic agenda, aimed at boosting US competitiveness and narrowing the trade deficit, with significant implications for global central banks and currency markets.
UK Labour leader Keir Starmer urges sustained engagement with Beijing, countering Donald Trump's call for Western disengagement and highlighting deepening geopolitical divides.
A Florida family’s dream home purchase turned into a financial nightmare after discovering a hidden $45,000 lien attached to solar panels advertised as ‘free.’ The case highlights critical pitfalls in the booming residential solar market.
Facing declining core automotive revenue, Tesla announces a radical strategic shift, halting production of flagship luxury models to fund a massive push into robotics and autonomous vehicles. Investors are left weighing ambitious promises against a backdrop of financial strain.
Russia's former president Dmitry Medvedev cautions that the potential lapse of the last major U.S.-Russia nuclear arms treaty without a successor could plunge the world into an unprecedented era of strategic instability unseen since the Cold War.
Igor Runets, founder and CEO of Russia's largest Bitcoin mining operator BitRiver, has been detained and placed under house arrest on charges of large-scale tax evasion. The case unfolds against a backdrop of Western sanctions and operational challenges for the once-dominant firm.
The iconic pottery maker reports encouraging sales growth and a renewed focus on its craft heritage, aiming to return to profitability next year after a period of job cuts and industry-wide challenges.
Amidst the allure of high-growth tech narratives, Acsion (JSE:ACS) presents a case for steady, profitable growth. With strong insider alignment and improving margins, does this property-focused stock warrant a closer look from discerning investors?
Tripadvisor and Best Western's new AI-driven travel platform for the 2026 FIFA World Cup showcases the company's potential in high-stakes tourism. Yet, for investors, the real test remains translating innovation into sustained growth and market-beating returns.
CONMED's latest earnings reveal a strategic pivot towards higher-growth surgical platforms, moving away from slower gastroenterology lines. While sales climbed, profitability softened, setting the stage for a crucial transition year as the market weighs the company's reset valuation against its ambitious 2026 roadmap.
As winter deepens and Russian strikes intensify, President Zelenskyy announces a new diplomatic push for peace, with talks scheduled this week in the UAE. The negotiations unfold against a backdrop of skepticism and a humanitarian crisis fueled by attacks on critical infrastructure.
Oil prices plunged and precious metals extended their historic sell-off as easing US-Iran tensions and President Trump's hawkish nominee for Federal Reserve Chair triggered a dramatic dollar rally, sending shockwaves through global markets.
